ADVERTISEMENT

Strides Pharma - Regrouping CDMO Pieces To Unlock Value: ICICI Securities

Strides shareholders to own 44% stake in new entity.

<div class="paragraphs"><p>Representational image of a drug manufacturing facility. (Source: Strides Pharma website)</p></div>
Representational image of a drug manufacturing facility. (Source: Strides Pharma website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit